Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study

By afschroeder • August 7, 2025

Armstrong A, Strober B, Gisondi P, Orroth KK, Cordey M, Kent ST, Deignan C, Jardon S, Hernandez RK, Brookhart MA, Stein Gold L. Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study. Dermatol Ther (Heidelb). 2025 Aug 6. doi: 10.1007/s13555-025-01466-3. Epub ahead of print. PMID: 40767996.

Tags: apremilast, Dermatology, disease burden, Phosphodiesterase 4 inhibitors, psoriasis, Publications, real-world, Topical drug administration

Upadacitinib for Alopecia: Current Evidence and Clinical Insights

Stirrat T, Thakker S, Bejugam D, Goh C, Lipner SR. Upadacitinib for Alopecia: Current Evidence and Clinical Insights. Skin Appendage Disord. 2025 Aug;11(4):320-334. doi: 10.1159/000544868.[...]

Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases

Shucheng H, Armstrong AW, Eidsmo L, Poddubnyy D. Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases. J Rheumatol. 2025[...]

Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting

Romanelli S, Childs B, Strand V, Armstrong AW, Perez-Chada LM, Merola JF, Gottlieb AB. Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual[...]